MS
Mark Schoenberg sold $37K of URGN stock
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN), sold 871 shares of URGN stock worth $37K, per an SEC Form 4 filed Sep 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 7, 2026, 2 days before it was made public.
URGN has moved -37.3% since the trade date, from $44.09 to $27.65 (Nov 20, 2026 close).
- Traded
- Sep 7, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 2 days
- Price since
- -37.3%
- Role
- Chief Medical Officer
- Source
- SEC Form 4